Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ZYMEZYME

Showing 0 of 17 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ZYMEWORKS INC

As of its Q3 2022 13F, Citadel Advisors held 123,327 shares of ZYME (Zymeworks), worth $758,000. Citadel Advisors' 13F filings listed ZYME from Q4 2019 to Q3 2022, 12 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used